
Order Summary & Billing Information
Published: Feb-2021 |
Report ID: HLCA2125 |
Pages: 1 - 250 |
Available Formats*: |
Visit Report |
Report Title
Global T-Cell Therapy Market by Modality (Research, and Commercialized), By Therapy (CAR T-Cell Therapy, T Cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes), By Indication (Hematologic Malignancies (Lymphoma, Leukemia, and Myeloma) and Solid Tumors (Melanoma, Brain & Central Nervous System, Liver cancer and others)), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
License
Price
$ 3400
100% Secure Payment






Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.